A toxin produced by E. coli may be driving rates of bowel cancer in young people in the United Kingdom, scientists have discovered.Experts believe the finding could help explain why rates of bowel ...

A bacterial toxin called colibactin, produced by certain strains of E. coli, appears to alter gut DNA in a way that prompts ...

A genetic signature including four genes in gastric cancer is linked to an increase in recurrence and mortality.

The toxin is known as colibactin. It is produced by certain strains of Escherichia coli that reside in the colon and rectum, ...

DELFI Diagnostics has clinically validated FirstLook Lung, its blood test designed to improve early detection of lung cancer, ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

Two Utah sisters have each had their entire stomach removed as a preventive measure to spare painful, cancer-filled future ...

HT-KIT, a novel targeted therapy for GIST, demonstrated the ability to reduce tumor burden in humanized mouse models and induce tumor cell death.

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Dostarlimab effectively eliminates the need for surgery in patients with advanced mismatch repair-deficient (dMMR) tumors, ...

New research published in Nature reveals that age-related changes in the gut promote the growth of pre-leukemic blood cells.